Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q2 2024 Earnings Call Transcript

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q2 2024 Earnings Call Transcript August 14, 2024

Matinas BioPharma Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.02 EPS, expectations were $-0.02.

Operator: Welcome to the Matinas BioPharma Second Quarter 2024 Financial Results Conference Call. Currently all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this...